NCT06544720View on ClinicalTrials.gov

SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas

PHASE1RecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 2, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Human Papillomavirus Associated CarcinomasCervical CancerHead and Neck CancersAnal CancerVulva CancerVaginal CancerPenile CancerHPV-Related Malignancy
Interventions
BIOLOGICAL

SCG142 TCR-T cells

Monotherapy of SCG142

Trial Locations (1)

266071

RECRUITING

The affiliated hosptial of qingdao university, Qingdao

All Listed Sponsors
lead

The Affiliated Hospital of Qingdao University

OTHER